SCHEMBL9102

SCHEMBL9102

COc1ccc([C](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.69
CES1 P23141 2/20 0.69
CA4 P22748 1/20 0.59
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
LTA4H P09960 1/20 0.56
NPC1 O15118 5/20 0.53
RAB9A P51151 5/20 0.53
MAPT P10636 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
CA12 O43570 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
KDM4E B2RXH2 2/20 0.52
HPGD P15428 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7953 1.00 CES2 (0.69) CES2CES1CA4CA1CA2
SCHEMBL5024814 0.92 CES2 (0.60) CES2CES1CA4CA1CA2
SCHEMBL41021 0.90 CA1 (0.65) CES2CES1CA1CA2MAPT
SCHEMBL17080311 0.90 CES2 (0.69) CES2CES1CA1CA2NPC1
SCHEMBL719395 0.87 CES2 (0.55) CES2CES1CA4CA1CA2
SCHEMBL2761265 0.87 CES2 (0.55) CES2CES1CA4CA1CA2
SCHEMBL8823207 0.87 CES2 (0.55) CES2CES1CA4CA1CA2
SCHEMBL6682499 0.87 CES2 (0.55) CES2CES1CA4CA1CA2
SCHEMBL14856629 0.87 CES2 (0.55) CES2CES1CA4CA1CA2
SCHEMBL10518077 0.86 CES2 (0.69) CES2CES1CA4CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 21760 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043642-B2 Process for the purification of oligonucleotides GENENTECH, INC. (US) 2024-07-23 US claimed
WO-2024149093-A1 GLUCOCORTICOID RECEPTOR AGONIST AND CONJUGATE THEREOF 四川科伦博泰生物医药股份有限公司 2024-07-18 WO claimed
EP-4039690-B1 A SUBSTANTIALLY DIASTEREOMERICALLY PURE PHOSPHORAMIDOCHLORIDATE, A METHOD AND A PHARMACEUTICAL COMPOSITION EISAI R&D MAN CO LTD (JP) 2024-07-17 EP claimed
CN-118345073-A GalNAc derivative 詹森生物制药有限公司 2024-07-16 CN claimed
EP-4396193-A1 FUNCTIONALIZED N-ACETYLGALACTOSAMINE ANALOGS Hongene Biotech Corporation (US) 2024-07-10 EP claimed
US-12030907-B2 Modified nucleoside phosphoramidites Janssen Biopharma, Inc. (US) 2024-07-09 US claimed
CN-118317970-A Synthesis of 2' acetyl-ester protected nucleosides 兆维生物科技公司 2024-07-09 CN claimed
CN-118290429-A Preparation method of non-zolpidem intermediate and non-zolpidem 山东百诺医药股份有限公司 2024-07-05 CN claimed
US-20240218365-A1 FORMULATION OF AN ANTISENSE OLIGOMER CONJUGATE THE PROGERIA RESEARCH FOUNDATION, INC. 2024-07-04 US claimed
EP-4392558-A1 ANTISENSE OLIGONUCLEOTIDES HAVING ONE OR MORE ABASIC UNITS Sarepta Therapeutics, Inc. (US) 2024-07-03 EP claimed
EP-0058563-A1 Lyophilized phosphorylated nucleosides ens BIO LOGICALS INC. (CA) 1982-08-25 EP claimed
US-4335240-A Process for cyclization ELI LILLY AND COMPANY (US) 1982-06-15 US claimed
EP-0049072-A1 Guanine compounds and their use for the preparation of anti-viral agents SYNTEX (U.S.A.) INC. (US) 1982-04-07 EP claimed
US-4310662-A Nucleosidic phosphorylating agent and methods GENENTECH, INC. (US) 1982-01-12 US claimed
US-4302391-A Unsymmetrical azetidinone aldehyde disulfides and process ELI LILLY AND COMPANY (US) 1981-11-24 US claimed
US-4293493-A Azetidinone alcohol disulfides and process for cyclization ELI LILLY AND COMPANY (US) 1981-10-06 US claimed
US-4293495-A Symmetrical azetidinone aldehyde disulfides and process ELI LILLY AND COMPANY (US) 1981-10-06 US claimed
EP-0035719-A2 Process for producing modified inorganic polymers, their use in producing polynucleotides, and a reagent useful in these processes UNIVERSITY PATENTS, INC. (US) 1981-09-16 EP claimed
EP-0035255-A1 Process for removing trityl blocking groups from 5'-O trityl nucleosides and oligonucleotides UNIVERSITY PATENTS, INC. (US) 1981-09-09 EP claimed
EP-0002322-A2 Improved Triester process for the synthesis of oligonucleotides GENENTECH, INC. (US) 1979-06-13 EP claimed